COLL vs PSX · P/E 17, rev $181.9M vs P/E 17, rev $143.15B
Collegium Pharmaceutical Inc (COLL) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported PSX revenue for 2024-12-31 was $143.15B. Net income was $2.17B. Revenue was down 2.9% from 2023-12-31 to 2024-12-31. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the COLL and PSX stock pages for the full models.
Not investment advice.